Spots Global Cancer Trial Database for stem cell transplantation
Every month we try and update this database with for stem cell transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer | NCT00312429 | Hematologic Neo... | Stem Cell Trans... | 18 Years - 70 Years | Duke University | |
| Expressive Helping for Stem Cell Transplant Patients | NCT03800758 | Stem Cell Trans... Hematologic Mal... | Expressive Help... Factual Writing | 18 Years - | Northwestern University | |
| Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation | NCT00795548 | Myelodysplastic... Acute Myeloid L... | 5-Azacitidine | 18 Years - | Heinrich-Heine University, Duesseldorf | |
| Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies | NCT00186823 | Leukemia, Acute... Leukemia, Myelo... Leukemia, Myelo... Juvenile Myelom... Hemoglobinuria,... Lymphoma, Non-H... Myelodysplastic... | Miltenyi Biotec... Stem Cell Trans... TBI, systemic c... | 2 Years - 21 Years | St. Jude Children's Research Hospital | |
| Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy | NCT00205764 | Multiple Myelom... | Melphalan | 19 Years - 70 Years | Austrian Forum Against Cancer | |
| Nilotinib Pre and Post Allogeneic Stem Cell Transplantation | NCT00750659 | Chronic Myeloid... Acute Lymphobla... Stem Cell Trans... | Nilotinib | 18 Years - 65 Years | Sheba Medical Center | |
| Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors | NCT01342237 | Brain Tumors | HDCT 1(TTC), HD... | - | Seoul National University Hospital | |
| Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy | NCT00303719 | Kidney Cancer Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | anti-thymocyte ... cyclophosphamid... cyclosporine fludarabine mycophenolate m... stem cell trans... total body irra... filgrastim | - 75 Years | Masonic Cancer Center, University of Minnesota | |
| Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM) | NCT03795597 | Multiple Myelom... | Carfilzomib Busulfan IV Melphalan IV | 18 Years - | Loyola University | |
| Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation | NCT03680092 | GVHD Hematologic Neo... | Cyclophosphamid... abatacept Methotrexate Tacrolimus | 18 Years - | University of California, San Diego | |
| Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM) | NCT03795597 | Multiple Myelom... | Carfilzomib Busulfan IV Melphalan IV | 18 Years - | Loyola University | |
| Cellular Therapy With Cord Blood Cells | NCT00427557 | Multiple Myelom... Leukemia Lymphoma | Fludarabine Melphalan Umbilical Cord ... Rituximab Peripheral Bloo... | - 80 Years | M.D. Anderson Cancer Center | |
| Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination | NCT00442130 | Chronic Lymphoc... | GM-K562 vaccine stem cell trans... | 18 Years - | Dana-Farber Cancer Institute | |
| Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma | NCT00539500 | Neuroblastoma | Carboplatin Etoposide Melphalan Stem Cell Infus... ClinicMACS | - | M.D. Anderson Cancer Center | |
| Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors | NCT00179816 | Ewing's Sarcoma Soft Tissue Sar... Hepatoblastoma Hodgkin's Disea... Germ Cell Tumor | High-Dose Chemo... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | NCT02881086 | Acute Lymphobla... Lymphoblastic L... | Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone | 18 Years - 55 Years | Goethe University | |
| Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts | NCT00968396 | Multiple Myelom... | Apheresis Stem Cell Trans... Melphalan | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients | NCT00661544 | Multiple Myelom... Stem Cell Trans... | Arsenic Trioxid... Melphalan Ascorbic Acid | - 70 Years | M.D. Anderson Cancer Center | |
| High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT | NCT00858793 | AIDS-related Ly... HIV Infections | PBSC-M87o, Gene... | 18 Years - 65 Years | Universitätsklinikum Hamburg-Eppendorf | |
| FLYSYN in MRD Positive AML | NCT02789254 | Acute Myeloid L... | FLYSYN | 18 Years - | Synimmune GmbH | |
| Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers | NCT00051311 | Hematologic Neo... | Stem cell trans... Fludarabine Cyclophosphamid... Etoposide Doxorubicin Vincristine Prednisone Methotrexate Cyclosporine Apheresis | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies | NCT00013533 | Hodgkin Lymphom... Lymphocytic Leu... Mixed Cell Leuk... Myelodysplastic... Non Hodgkin's L... CML ALL AML Lymphoma | Stem cell trans... | 4 Years - 20 Years | National Institutes of Health Clinical Center (CC) | |
| Serum Free Light Change in Multiple Myeloma | NCT00910078 | Multiple Myelom... | 18 Years - 75 Years | Azienda Ospedaliera San Giovanni Battista | ||
| Infections in Pediatric Cancer Patients | NCT00930267 | Infections | - 18 Years | Hadassah Medical Organization | ||
| Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients | NCT00195533 | Hematological M... Leukemia Myelodysplasia Lymphoma Myeloma Stem Cell Trans... | piperacillin-ta... glycopeptide | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma | NCT01208896 | Lymphoma, Folli... Stem Cell Trans... | Reduced_intensi... | 18 Years - 65 Years | University Hospital, Bordeaux | |
| Umbilical Cord Transplantation for the Elderly Population | NCT01484470 | Hematologic Mal... | StemEx | 55 Years - 73 Years | Loyola University | |
| Cellular Therapy With Cord Blood Cells | NCT00427557 | Multiple Myelom... Leukemia Lymphoma | Fludarabine Melphalan Umbilical Cord ... Rituximab Peripheral Bloo... | - 80 Years | M.D. Anderson Cancer Center | |
| Efficacy of G-CSF-Priming in Elderly AML Patients | NCT00199147 | Acute Myeloid L... | Cytarabine Etoposide Idarubicin G-CSF Fludarabine Stem cell apher... Stem cell trans... | 61 Years - | Johann Wolfgang Goethe University Hospital | |
| Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant | NCT04511130 | Acute Myeloid L... Stem Cell Trans... | MT-401 | 18 Years - | Marker Therapeutics, Inc. | |
| Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure | NCT03323541 | Multiple Myelom... Non-hodgkin Lym... Hodgkin Lymphom... | Filgrastim Pref... | 18 Years - | University Hospital, Brest | |
| IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome | NCT00469144 | Myelodysplastic... Leukemia Acute Myeloid L... | Busulfan Fludarabine | - 65 Years | M.D. Anderson Cancer Center | |
| Stem Cell Transplantation to Treat Systemic Mastocytosis | NCT00006413 | Mastocytosis | Stem cell trans... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Pre-Exercise for Allogeneic Stem Cell Transplant Patients | NCT03080792 | Cancer, Hematol... | Experimental: m... | 18 Years - | University Hospital Heidelberg | |
| Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion | NCT00966810 | Philadelphia Ch... | Stem cell trans... | 18 Years - 65 Years | Rambam Health Care Campus | |
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma | NCT00306111 | Non-Hodgkin Lym... | pegfilgrastim | 18 Years - | University Hospital Tuebingen | |
| Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants | NCT00606437 | Lymphoma Myeloma Leukemia Myelodysplasia Solid Tumors Hodgkin's Disea... Myelofibrosis | Total Body Irra... | 14 Years - 65 Years | Duke University | |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | NCT02881086 | Acute Lymphobla... Lymphoblastic L... | Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone | 18 Years - 55 Years | Goethe University | |
| Study to Test a Computer-assisted Support System to Improve Patient-centered Care and Symptom Relief in Cancer Patients | NCT00709813 | Cancer Lymphoma Leukemia Stem Cell Trans... | Tailored assess... | 18 Years - | Oslo University Hospital | |
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib | NCT02489500 | AL Amyloidosis | Bortezomib Melphalan Neupogen Stem Cell Colle... Stem cell infus... | 18 Years - | Boston Medical Center | |
| A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas | NCT00521560 | Primary Non-Hod... Refractory Non-... CD20+ Aggressiv... | Zevalin | 18 Years - 65 Years | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | |
| Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation | NCT00593645 | Myelodysplastic... Acute Myeloid L... | Clofarabine Cytarabine Thymoglobulin Stem cell infus... | 18 Years - | Washington University School of Medicine | |
| Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies | NCT00145613 | Acute Lymphobla... Acute Myeloid L... Secondary AML Myelodysplastic... Secondary MDS Chronic Myeloid... Juvenile Myelom... Paroxysmal Noct... Lymphoma, Non-H... Hodgkin Disease | Stem Cell Trans... Miltenyi Biotec... Systemic chemot... | 2 Years - 21 Years | St. Jude Children's Research Hospital | |
| Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases | NCT05800210 | Acute Lymphobla... Acute Myeloid L... Juvenile Myelom... Myelodysplastic... Chronic Myeloid... Lymphoma, Non-H... Lymphoma, Hodgk... | Miltenyi CliniM... | 6 Months - 39 Years | University of Florida | |
| Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation | NCT04691284 | Hematologic Neo... | Blood, urine an... | 18 Years - | National Cancer Institute, Slovakia | |
| Infections in Pediatric Cancer Patients | NCT00930267 | Infections | - 18 Years | Hadassah Medical Organization | ||
| A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy | NCT00833560 | Multiple Myelom... | Cyclophosphamid... Bortezomib Dexamethasone | 18 Years - 60 Years | Janssen-Cilag G.m.b.H | |
| Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation | NCT01800643 | Acute Leukemia Chronic Leukemi... Lymphoprolifera... Myeloproliferat... Immunodeficienc... | Analyze the pha... | - | Hospital Israelita Albert Einstein | |
| Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies | NCT00566696 | Leukemia, Acute... Leukemia, Myelo... Leukemia, Myelo... Juvenile Myelom... Hemoglobinuria,... Hodgkin Lymphom... Lymphoma, Non-H... Myelodysplastic... | CliniMACS Stem cell trans... Fludarabine Thioplex® L-phenylalanine... Mycophenolate m... Rituxan™ Alemtuzumab Cyclophosphamid... Anti-thymocyte ... G-CSF Muromonab | - 21 Years | St. Jude Children's Research Hospital | |
| Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies | NCT02566395 | Acute Lymphobla... Acute Myelogeno... Myelodysplastic... Chronic Myeloge... Non-Hodgkin Lym... Hodgkin Lymphom... | Radiation Cyclophosphamid... Donor Lymphocyt... Haploidentical ... | 2 Years - 21 Years | Northwell Health | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients | NCT00195533 | Hematological M... Leukemia Myelodysplasia Lymphoma Myeloma Stem Cell Trans... | piperacillin-ta... glycopeptide | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome | NCT00469144 | Myelodysplastic... Leukemia Acute Myeloid L... | Busulfan Fludarabine | - 65 Years | M.D. Anderson Cancer Center | |
| Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation | NCT01800643 | Acute Leukemia Chronic Leukemi... Lymphoprolifera... Myeloproliferat... Immunodeficienc... | Analyze the pha... | - | Hospital Israelita Albert Einstein | |
| Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma | NCT01208896 | Lymphoma, Folli... Stem Cell Trans... | Reduced_intensi... | 18 Years - 65 Years | University Hospital, Bordeaux | |
| Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma | NCT00781170 | Multiple Myelom... Stem Cell Trans... | allogeneic hema... | 18 Years - 66 Years | Universitätsklinikum Hamburg-Eppendorf | |
| ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) | NCT02670564 | Acute Lymphobla... | Pharmacogenomic... Busulfan plasma... | - 18 Years | Swiss Pediatric Oncology Group | |
| High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease | NCT01200329 | Lymphoma | Gemcitabine Busulfan Melphalan Stem Cell Trans... Palifermin | 12 Years - 70 Years | M.D. Anderson Cancer Center | |
| FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma | NCT00530179 | Diffuse Large B... | Autologous Bloo... R-CHOP | 18 Years - 65 Years | AHS Cancer Control Alberta | |
| Airway Reactivity in Children Before and After BMT Bone Marrow Transplantation | NCT00771836 | Cancer | 4 Years - 20 Years | Rambam Health Care Campus | ||
| Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies | NCT00113828 | Lymphoma Leukemia Multiple Myelom... Myelodysplastic... | Non-myeloablati... T-cell depleted... | 18 Years - 65 Years | Massachusetts General Hospital | |
| NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia | NCT00476541 | Acute Myeloid L... | Gemtuzumab ozog... | 1 Day - 18 Years | University of Aarhus | |
| Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy | NCT00303719 | Kidney Cancer Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | anti-thymocyte ... cyclophosphamid... cyclosporine fludarabine mycophenolate m... stem cell trans... total body irra... filgrastim | - 75 Years | Masonic Cancer Center, University of Minnesota | |
| Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation | NCT03276481 | Multiple Myelom... | Oral microbiota... Comprehensive c... Measurement of ... Surveys assessi... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies | NCT02566395 | Acute Lymphobla... Acute Myelogeno... Myelodysplastic... Chronic Myeloge... Non-Hodgkin Lym... Hodgkin Lymphom... | Radiation Cyclophosphamid... Donor Lymphocyt... Haploidentical ... | 2 Years - 21 Years | Northwell Health | |
| Cord Blood Stem Cell Transplantation Study (COBLT) | NCT00000603 | Anemia, Aplasti... Fanconi Anemia Hematologic Dis... Leukemia Neoplasms Severe Combined... Hematopoietic S... Myelodysplastic... | stem cell trans... | - 55 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma | NCT00778752 | Multiple Myelom... | Revlimid (Lenal... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf | |
| Infusion of Expanded Cord Blood T Cells | NCT00972101 | Stem Cell Trans... Leukemia Lymphoma Pediatric Disor... | Total Body Irra... Melphalan Thiotepa Fludarabine Rituximab Etoposide Anti-thymocyte ... Mycophenolate M... Tacrolimus Cord Blood Infu... G-CSF Ex vivo expande... | - 55 Years | M.D. Anderson Cancer Center | |
| Unrelated Double Umbilical Cord Blood Units Transplantation | NCT01015742 | Leukemia, Myelo... Leukemia, Lymph... Leukemia, Myelo... | Stem cell Trans... | 1 Year - 50 Years | Tehran University of Medical Sciences | |
| CT-011 MAb in DLBCL Patients Following ASCT | NCT00532259 | Lymphoma, Large... Lymphoma, Mixed... Primary Mediast... | CT-011 | 18 Years - | CureTech Ltd | |
| Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial | NCT00222027 | Acute Lymphobla... | Collection of t... | 15 Years - 59 Years | University Hospital, Toulouse | |
| Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies | NCT00013533 | Hodgkin Lymphom... Lymphocytic Leu... Mixed Cell Leuk... Myelodysplastic... Non Hodgkin's L... CML ALL AML Lymphoma | Stem cell trans... | 4 Years - 20 Years | National Institutes of Health Clinical Center (CC) | |
| Stem Cell Transplantation to Treat Systemic Mastocytosis | NCT00006413 | Mastocytosis | Stem cell trans... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation | NCT00219726 | Chronic Myeloid... | Imatinib mesyla... | 18 Years - | Poitiers University Hospital | |
| Effect of Mobile Application on Supportive Care Needs and Quality of Life Patients Undergoing Hematopoietic Stem Cell Transplantation | NCT05609227 | Hematologic Mal... Patient Educati... | mobile applicat... | 18 Years - | Baskent University | |
| FLYSYN in MRD Positive AML | NCT02789254 | Acute Myeloid L... | FLYSYN | 18 Years - | Synimmune GmbH | |
| Expressive Helping for Stem Cell Transplant Patients | NCT03800758 | Stem Cell Trans... Hematologic Mal... | Expressive Help... Factual Writing | 18 Years - | Northwestern University | |
| Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells | NCT00398411 | Hodgkin Disease Non-Hodgkin Lym... Multiple Myelom... Bacteremia | moxifloxacin placebo | 18 Years - 75 Years | University of Cologne |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
